Endometrioid Carcinoma
5 clinical trials · Condition
◉ Watch Endometrioid Carcinoma
| Record | Firm | Date |
|---|---|---|
| PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer (NCT06549855) | Peking University People's Hospital | 2024-09-02 |
| Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer (NCT05080556) | University College, London | 2023-05-24 |
| Phase I Trial of Defactinib and VS-6766. (NCT03875820) | Institute of Cancer Research, United Kingdom | 2017-12-12 |
| Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence. (NCT02598219) | Centre Oscar Lambret | 2015-11-01 |
| Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC) (NCT01732432) | University Hospital, Basel, Switzerland | 2012-10-01 |
Track Endometrioid Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.